StockData
MariMed Inc. logo

MariMed Inc. (MRMD) stock

MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.06−0.00 (-3.39%)

Close on Oct 19, 2026Market cap $22.97MP/E –Yield –

MariMed revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

MariMed's revenue for the twelve months ending Sep 30, 2026 was $167.28M, up 6.5% year over year. For fiscal 2025 it was $159.83M, up 1.3% from the year before. Over ten years it grew 62.2% a year on average. The highest annual figure on record is $159.83M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$159.83M+1.3%
FY2024Dec 31, 2024$157.71M+6.1%
FY2023Dec 31, 2023$148.60M+10.9%
FY2022Dec 31, 2022$134.01M+10.3%
FY2021Dec 31, 2021$121.46M+138.7%
FY2020Dec 31, 2020$50.90M+11.6%
FY2019Dec 31, 2019$45.60M+284.8%
FY2018Dec 31, 2018$11.85M+95.3%
FY2017Dec 31, 2017$6.07M+70.2%
FY2016Dec 31, 2016$3.56M+180.6%
FY2015Dec 31, 2015$1.27M+1337.1%
FY2014Dec 31, 2014$88.38K+9677.0%
FY2013Dec 31, 2013$904+15.2%
FY2012Dec 31, 2012$785–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$44.23M+8.5%
Q2 FY2026Jun 30, 2026$41.93M+6.1%
Q1 FY2026Mar 31, 2026$39.48M+4.2%
Q4 FY2025Dec 31, 2025$41.65M+6.9%
Q3 FY2025Sep 30, 2025$40.76M+0.4%
Q2 FY2025Jun 30, 2025$39.51M-2.3%
Q1 FY2025Mar 31, 2025$37.91M-0.1%
Q4 FY2024Dec 31, 2024$38.95M+0.1%
Q3 FY2024Sep 30, 2024$40.60M+4.6%
Q2 FY2024Jun 30, 2024$40.44M+10.7%
Q1 FY2024Mar 31, 2024$37.93M+10.3%
Q4 FY2023Dec 31, 2023$38.90M+8.6%
Q3 FY2023Sep 30, 2023$38.80M+14.4%
Q2 FY2023Jun 30, 2023$36.52M+10.7%
Q1 FY2023Mar 31, 2023$34.38M+9.9%
Q4 FY2022Dec 31, 2022$35.83M+15.4%
Q3 FY2022Sep 30, 2022$33.91M+37.6%
Q2 FY2022Jun 30, 2022$32.99M+62.0%
Q1 FY2022Mar 31, 2022$31.28M+132.4%
Q4 FY2021Dec 31, 2021$31.04M+223.0%
Q1 FY2021Mar 31, 2021$24.64M+230.1%
Q4 FY2020Dec 31, 2020$20.36M+292.1%
Q3 FY2020Sep 30, 2020$13.46M+19.9%
Q2 FY2020Jun 30, 2020$9.61M-62.6%
Q1 FY2020Mar 31, 2020$7.47M+112.4%
Q4 FY2019Dec 31, 2019$5.19M+50.9%
Q3 FY2019Sep 30, 2019$11.22M+230.9%
Q2 FY2019Jun 30, 2019$25.67M+774.0%
Q1 FY2019Mar 31, 2019$3.52M+68.8%
Q4 FY2018Dec 31, 2018$3.44M+117.7%
Q3 FY2018Sep 30, 2018$3.39M+97.7%
Q2 FY2018Jun 30, 2018$2.94M+81.2%
Q1 FY2018Mar 31, 2018$2.08M+81.0%
Q4 FY2017Dec 31, 2017$1.58M+10.6%
Q3 FY2017Sep 30, 2017$1.72M+96.4%
Q2 FY2017Jun 30, 2017$1.62M–
Q1 FY2017Mar 31, 2017$1.15M–
Q4 FY2016Dec 31, 2016$1.43M–
Q3 FY2016Sep 30, 2016$873.55K–

More MariMed figures

See a number that looks wrong?